In an observational cohort of patients with atrial fibrillation, obese patients were less likely than nonobese patients to avoid symptomatic recurrence on sodium channel blocking agents in contrast to a roughly equivalent response in both groups to potassium channel blocking agents.
The U.S. Preventive Services Task Force evaluated the risks and benefits of interventions for weight loss and weight loss maintenance to prevent complications from obesity and found a moderate net benefit from weight loss-intensive behavioral interventions.
Lifestyle is a critical determinant of the common risk factors for cardiovascular disease (hypertension, diabetes, hyperlipidemia, and smoking) that have been well-known to predict disease outcomes. Lifestyle medicine can be used in conjunction with traditional medications to provide the best care to patients. Clinicians need to act now to prevent being overwhelmed with the eventual increase in coronary artery disease following the obesity/diabetes epidemic.
Overweight and obesity have reached epidemic proportions in the United States. For individuals affected by obesity, clinical studies have shown that carbohydrate restriction, including a low-carbohydrate, ketogenic diet, can be a safe and effective treatment. This article includes a narrative review of clinical research studies and a practical description of implementing a “keto” diet for obesity.
Results from a large retrospective study of women undergoing cervical cancer screening indicate that overweight and obese women had an increased risk of cervical cancer compared to normal weight women.